FGF21 and metabolic dysfunction-associated steatotic liver disease: Previous studies have shown that plasma level of FGF21 is elevated in NAFLD patients, and it is positively correlated with high liver fat in both mice and human (Dushay et al, 2010; Li et al, 2010, 2013; Rusli et al, 2016).